A Nagai, WM Thurlbeck and K Konno
First Department of Medicine, Tokyo Women's Medical College, Japan.

We have studied the relationships between pulmonary lesions and bronchodilator response and variability of FEV1 in 41 patients enrolled in the National Institutes of Health Intermittent Positive Pressure Breathing Trial who died, came to autopsy, and provided adequate tissue to quantitate lesions. The patients had moderate to severe chronic airflow obstruction and various degrees of response to 250 micrograms isoproterenol inhalation. Airway responsiveness was positively correlated with bronchial eosinophilia, bronchial inflammation, and bronchiolar fibrosis, and it was negatively correlated with bronchiolar goblet cell metaplasia and emphysema. Patients with an increase of 190 ml or more in FEV1 after bronchodilator had less bronchial cartilage and less goblet metaplasia in bronchioles. Airway smooth muscle was not related to airway responsiveness and variability. Flow rates were adversely affected by bronchial eosinophilia for given emphysema scores. This study shows the importance of the eosinophil as part of chronic nonspecific lung disease. Lack of airway responsiveness was associated with lesions such as emphysema and goblet cell metaplasia, which by themselves cause severe chronic airflow obstruction. The better-preserved lung function in patients with increased airway responsiveness is attributed to negative correlations with emphysema and positive correlations with bronchial eosinophilia.

This article has been cited by other articles:

				A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF]

				B.W.M. Willemse, N.H.T. ten Hacken, B. Rutgers, I.G.A.T. Lesman-Leegte, W. Timens, and D.S. Postma Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Eur. Respir. J., September 1, 2004; 24(3): 391 - 396. [Abstract] [Full Text] [PDF]

				G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]

				D. A. Yablonskiy, A. L. Sukstanskii, J. C. Leawoods, D. S. Gierada, G. L. Bretthorst, S. S. Lefrak, J. D. Cooper, and M. S. Conradi Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI PNAS, February 20, 2002; (2002) 52594699. [Abstract] [Full Text] [PDF]

				H. TIDDENS, M. SILVERMAN, and A. BUSH The Role of Inflammation in Airway Disease . Remodeling Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S7 - 10. [Full Text] [PDF]

				M. G. COSIO and A. GUERASSIMOV Chronic Obstructive Pulmonary Disease . Inflammation of Small Airways and Lung Parenchyma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S21 - 25. [Abstract] [Full Text] [PDF]

				L. Davies, M. Nisar, M.G. Pearson, R.W. Costello, J.E. Earis, and P.M.A. Calverley Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease QJM, July 1, 1999; 92(7): 395 - 400. [Abstract] [Full Text] [PDF]

				T. A. R. SEEMUNGAL, G. C. DONALDSON, E. A. PAUL, J. C. BESTALL, D. J. JEFFRIES, and J. A. WEDZICHA Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 1418 - 1422. [Abstract] [Full Text]

				D. A. Yablonskiy, A. L. Sukstanskii, J. C. Leawoods, D. S. Gierada, G. L. Bretthorst, S. S. Lefrak, J. D. Cooper, and M. S. Conradi Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI PNAS, March 5, 2002; 99(5): 3111 - 3116. [Abstract] [Full Text] [PDF]